Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy

Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy

Background: This study aimed to evaluate the effect of salvage therapy with nab-paclitaxel (nab-p) or temozolomide (TMZ) combined with antiangiogenic drugs in programmed death 1 (PD-1) inhibitor-resistant patients with unresectable metastatic melanoma. Methods: We conducted a retrospective review of...

Full description

Bibliographic Details
Main Authors: Xuan Wang, Weiran Xu, Zhihong Chi, Lu Si, Xinan Sheng, Yan Kong, Li Zhou, Lili Mao, Bin Lian, Bixia Tang, Xieqiao Yan, Xue Bai, Chuanliang Cui, Jun Guo
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Translational Oncology
Subjects:
Melanoma
PD-1 inhibitor resistance
Chemotherapy
Antiangiogenic drugs
Nomogram
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320304411

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320304411

Similar Items